Classification of ANCA-Associated Vasculitis

被引:41
|
作者
Khan, Irfan [1 ]
Watts, Richard A. [1 ,2 ]
机构
[1] Ipswich Hosp NHS Trust, Dept Rheumatol, Ipswich IP4 5PD, Suffolk, England
[2] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England
关键词
Vasculitis; Classification; ANCA; Criteria; Chapel Hill Consensus Conference; Granulomatosis with polyangiitis; Microscopic polyangiitis; Eosinophilic granulomatosis with polyangiitis; Polyarteritis nodosa; RHEUMATOLOGY; 1990; CRITERIA; WEGENER GRANULOMATOSIS; SYSTEMIC VASCULITIS; MICROSCOPIC POLYANGIITIS; POLYARTERITIS-NODOSA; CONSENSUS CONFERENCE; NOMENCLATURE; ALGORITHM; RELAPSE;
D O I
10.1007/s11926-013-0383-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Classification of the ANCA-associated vasculitides remains controversial. Existing systems, developed by the American College of Rheumatology (ACR) in 1990, the Chapel Hill Consensus Conference (CHCC) in 1994 and updated in 2012, and the European Medicines Agency algorithm, all have deficiencies, especially when applied to unselected patients. The ACR system did not include ANCA or microscopic polyangiitis, and the CHCC (1994) included MPA but not ANCA (this was rectified in the 2012 revision). These systems were developed as classification criteria and not as diagnostic criteria. There are currently no validated diagnostic criteria for AAV. The Diagnostic and Classification Criteria for Vasculitis (DCVAS) study is a global study with the objective of developing and validating diagnostic criteria.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] ANCA-Associated Vasculitis: An Update
    Almaani, Salem
    Fussner, Lynn A.
    Brodsky, Sergey
    Meara, Alexa S.
    Jayne, David
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [42] Pathogenesis of ANCA-associated Vasculitis
    Flint, Julia
    Morgan, Matthew D.
    Savage, Caroline O. S.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : 463 - +
  • [43] Biomarkers in ANCA-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert F.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)
  • [44] Comorbidities in ANCA-associated vasculitis
    Kronbichler, Andreas
    Leierer, Johannes
    Gauckler, Philipp
    Shin, Jae Il
    [J]. RHEUMATOLOGY, 2020, 59 : 79 - 83
  • [45] Immunosuppression in ANCA-associated vasculitis
    van der Woude, FJ
    Schmitt, WH
    Birck, R
    Nowack, R
    Göbel, U
    Drexler, JM
    Hotta, O
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2225 - 2226
  • [46] Spectrum of ANCA-Associated Vasculitis
    Sinha, Aditi
    Bagga, Arvind
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2017, 84 (10): : 737 - 738
  • [47] Biomarkers in ANCA-Associated Vasculitis
    Lindsay Lally
    Robert F. Spiera
    [J]. Current Rheumatology Reports, 2013, 15
  • [48] Rituximab in ANCA-Associated Vasculitis
    Romina I. Hassan
    Angelo L. Gaffo
    [J]. Current Rheumatology Reports, 2017, 19
  • [49] Treatment of ANCA-associated vasculitis
    Ulf Schönermarck
    Wolfgang L. Gross
    Kirsten de Groot
    [J]. Nature Reviews Nephrology, 2014, 10 : 25 - 36
  • [50] Rituximab in ANCA-Associated Vasculitis
    Hassan, Romina I.
    Gaffo, Angelo L.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (02)